A recent study presented at the Psych Congress Elevate 2025 highlights the concerning issue of undertreated tardive dyskinesia in long-term care settings. Conducted by Teva, the research reveals that many patients in these facilities suffer from this debilitating movement disorder without adequate treatment. Tardive dyskinesia, often caused by prolonged use of certain medications, can lead to uncontrollable facial and body movements, significantly impacting quality of life. Despite effective treatment options being available, the data suggests a gap in proper diagnosis and management within care homes. This highlights an urgent need for improved awareness and educational efforts among healthcare providers to ensure patients receive appropriate care. Addressing this issue could lead to better outcomes and a higher quality of life for affected individuals. The study underlines the importance of regular monitoring and adjustment of treatment plans for long-term care residents.
Toronto StarNew data shows 90% of buyers unable to afford new Brisbane apartments
April 29, 2026
In Brisbane, a startling new statistic reveals that nine out of ten potential buyers are priced out of the city’s new apartment market. With soaring